Women with Gestational Diabetes Mellitus (GDM) are over three times more inclined towards risk of developing diabetes.
Therefore after studies European Union approved the use of insulin ‘aspart-NovoRapid’ on pregnant women with diabetes.
NovoRapid developed by pharmaceuticals major Novo Nordisc is the first new insulin that can be used in pregnancy.
Now, diabetic women that are expecting need not worry.
